scholarly article | Q13442814 |
P819 | ADS bibcode | 2014PLoSO...9k1881S |
P356 | DOI | 10.1371/JOURNAL.PONE.0111881 |
P932 | PMC publication ID | 4251827 |
P698 | PubMed publication ID | 25462870 |
P5875 | ResearchGate publication ID | 269169315 |
P2093 | author name string | Naomi Kobayashi | |
Shinya Kimura | |||
Seiji Okada | |||
Eisaburo Sueoka | |||
Naoko Sueoka-Aragane | |||
Masako Yokoo | |||
Masaru Ide | |||
Akemi Sato | |||
Yumi Nagano | |||
P2860 | cites work | Intratumor heterogeneity: evolution through space and time | Q24598678 |
Efficient tumour formation by single human melanoma cells | Q24648938 | ||
Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers | Q27852116 | ||
Epithelial-mesenchymal transitions in tumour progression | Q27860487 | ||
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing | Q27860948 | ||
Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice | Q28242854 | ||
Clonal evolution in cancer | Q29547696 | ||
Metastasis: from dissemination to organ-specific colonization | Q29614295 | ||
Analysis of circulating tumor DNA to monitor metastatic breast cancer | Q29614797 | ||
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA | Q29620083 | ||
Tumor heterogeneity: causes and consequences | Q33624298 | ||
Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients | Q33743256 | ||
About the possible origin and mechanism of circulating DNA apoptosis and active DNA release | Q34100424 | ||
Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA. | Q34278191 | ||
Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells | Q34416761 | ||
A new mouse model for the study of human breast cancer metastasis | Q34464714 | ||
Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer: direct quantitative PCR for ALU repeats | Q34530414 | ||
Multiple marker detection in peripheral blood for NSCLC diagnosis | Q34612077 | ||
Rebiopsy of lung cancer patients with acquired resistance to EGFR inhibitors and enhanced detection of the T790M mutation using a locked nucleic acid-based assay | Q34762839 | ||
Early development of human hematopoietic and acquired immune systems in new born NOD/Scid/Jak3null mice intrahepatic engrafted with cord blood-derived CD34 + cells. | Q51960368 | ||
Application of a highly sensitive detection system for epidermal growth factor receptor mutations in plasma DNA. | Q53103689 | ||
A fully integrated, automated and rapid detection system for KRAS mutations. | Q53241221 | ||
Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. | Q53376881 | ||
Non-obese diabetic-recombination activating gene-1 (NOD-Rag1 null) interleukin (IL)-2 receptor common gamma chain (IL2r gamma null) null mice: a radioresistant model for human lymphohaematopoietic engraftment. | Q53454854 | ||
Hepatocyte growth factor expression in EGFR mutant lung cancer with intrinsic and acquired resistance to tyrosine kinase inhibitors in a Japanese cohort. | Q54340897 | ||
Free DNA in the serum of cancer patients and the effect of therapy. | Q55492005 | ||
Novel metastasis model of human lung cancer in SCID mice depleted of NK cells | Q71406159 | ||
Comparison of drug sensitivity among tumor cells within a tumor, between primary tumor and metastases, and between different metastases in the human tumor colony-forming assay | Q72732664 | ||
Modeling metastasis in the mouse | Q84516681 | ||
A new modality for immunosuppression: targeting the JAK/STAT pathway | Q35825869 | ||
A novel animal model for bone metastasis in human lung cancer. | Q35995127 | ||
Mouse modeling in oncologic preclinical and translational research | Q36603691 | ||
Genetic determinants of cancer metastasis | Q36794312 | ||
Extracellular DNA in pancreatic cancer promotes cell invasion and metastasis. | Q37184055 | ||
Tracing the origins of metastasis | Q37815132 | ||
A noninvasive system for monitoring resistance to epidermal growth factor receptor tyrosine kinase inhibitors with plasma DNA. | Q38331849 | ||
NK314 potentiates antitumor activity with adult T-cell leukemia-lymphoma cells by inhibition of dual targets on topoisomerase II{alpha} and DNA-dependent protein kinase | Q39606092 | ||
Japanese Lung Cancer Registry Study: first prospective enrollment of a large number of surgical and nonsurgical cases in 2002. | Q39850702 | ||
Orthotopically implanted SCID mouse model of human lung cancer suitable for investigating metastatic potential and anticancer drug effects. | Q40502462 | ||
Sites of recurrence in resected stage I non-small-cell lung cancer: a guide for future studies | Q41410417 | ||
Cell-free nucleic acids circulating in the plasma of colorectal cancer patients induce the oncogenic transformation of susceptible cultured cells | Q42830431 | ||
DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. | Q43540280 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | e111881 | |
P577 | publication date | 2014-12-02 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Correlation between plasma DNA and tumor status in an animal model | |
P478 | volume | 9 |
Q37644972 | A lupus anti-DNA autoantibody mediates autocatalytic, targeted delivery of nanoparticles to tumors |
Q54984377 | Automated DNA extraction using cellulose magnetic beads can improve EGFR point mutation detection with liquid biopsy by efficiently recovering short and long DNA fragments. |
Q40581966 | DNA methylation screening of primary prostate tumors identifies SRD5A2 and CYP11A1 as candidate markers for assessing risk of biochemical recurrence. |
Q48004444 | Detection of KRAS Mutations in Plasma DNA Using a fully Automated Rapid Detection System in Colorectal Cancer Patients |
Q37060387 | Evaluation of a novel saliva-based epidermal growth factor receptor mutation detection for lung cancer: A pilot study |
Q36622073 | Monitoring EGFR T790M with plasma DNA from lung cancer patients in a prospective observational study |
Q37701499 | Total DNA input is a crucial determinant of the sensitivity of plasma cell-free DNA EGFR mutation detection using droplet digital PCR. |
Search more.